Insiders Updates Investing in Apimeds Pharmaceuticals US Inc (APUS): What You Must Know In a filing, Apimeds Pharmaceuticals US Inc revealed its Chairman and CMO Kim Christopher acquired Company’s shares for reported $35981.0